Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activity

Christine L Dixon, Neil L Harrison, Joseph W Lynch and Angelo Keramidas

Zolpidem and eszopiclone prime 122 GABAA receptors for longer duration of activity BACKGROUND AND PURPOSE GABAA receptors mediate neuronal inhibition in the brain. They are the primary targets for benzodiazepines, which are widely used to treat neurological disorders including anxiety, epilepsy and insomnia. The mechanism by which benzodiazepines enhance GABAA receptor activity has been extensively studied, but there is little mechanistic information on how non-benzodiazepine drugs that bind to the same site exert their effects. Eszopiclone and zolpidem are two non-benzodiazepine drugs for which no mechanism of action has yet been proposed, despite their clinical importance as sleeping aids. Here we investigate how both drugs enhance the activity of α1β2γ2 GABAA receptors.

Pro Vida

Pro Vida

es un  programa  integral,  diseñado  para proveer  diversos  beneficios a pacientes  crónicos. Descuentos  desde su  primera compra, alianzas  con Laboratorios  y  Centro  de Diagnóstico y charlas educacionales al paciente crónico.

Si su médico le ha recetado alguna de las marcas que incluye el programa y  desea obtener todos los beneficios que Provida le ofrece, favor comunicarse al Call Center, para afiliarse y ser parte del programa.

Productos destacados

It seems we can't find what you're looking for.